Evelo Biosciences CEO Balkrishan Gill's 2019 pay falls 37% to $2.8M
Evelo Biosciences reports 2019 executive compensation
By ExecPay News
Published: April 27, 2020
Evelo Biosciences reported fiscal year 2019 executive compensation information on April 27, 2020.
In 2019, three executives at Evelo Biosciences received on average a compensation package of $1.9M, a 41% decrease compared to previous year.
Average pay of disclosed executives at Evelo Biosciences
Balkrishan Simba Gill, Chief Executive Officer, received $2.8M in total, which decreased by 37% compared to 2018. 73% of Gill's compensation, or $2M, was in option awards. Gill also received $216K in non-equity incentive plan and $540K in salary.
Mark Bodmer, Chief Scientific Officer, received a compensation package of $1.5M. 63% of the compensation package, or $930K, was in option awards.
Jonathan Poole, Chief Financial Officer, earned $1.4M in 2019, a 52% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 27, 2020.